For Doctors

Cancer Gene Panels

XING Cancer Care specializes in genetic testing for a range of cancer types. We offer comprehensive genomic testing that pinpoints mutations that may be targeted with specific treatment options. Our aim is to provide a personalized report detailing the genetic characteristics of the tumour based on the detection of variants or mutations found in these genes. 

Please refer to the available gene panels below.

Homologous Recombination Deficiency (HRD)

 

The HRD panel is a multi-gene test that analyses the entire coding regions of 27 key genes involved in homologous recombination repair deficiency. This panel is aimed at breast, ovarian, prostate, and pancreatic cancers.

 

Cancer Type

Solid Tumour

Sample Type

FFPE Tissue/ Whole Blood

TAT

28 days

Key documents

Homologous Recombination Deficiency Gene List

Test Instructions

Request Form

Patient Consent Form

 

Solid Tumour Panel (STP)

 

The STP panel is a multi-gene test that analyses hotspot alterations considered to be driving mutations in solid tumours; includes hotspots in 47 genes involved in colorectal, melanoma, NSCLC, pancreatic, GIST, and glioma. 

 

Cancer Type

Solid Tumour

Sample Type

FFPE Tissue

TAT

28 days

Key documents

Solid Tumour Panel Gene List

Test Instructions

Request Form

Patient Consent Form

 

XGP72 

 

 

The XGP72 panel is a multi-gene test for cancer predisposition and targeted treatment. The test analyses coding regions of 72 of the most clinically relevant genes that are commonly associated with cancer or with an increased risk for cancer. 

Cancer Type

Solid Tumour

Sample Type

FFPE Tissue/ Whole Blood

TAT

28 days

Key documents

XGP72 Gene List

Test Instructions

Request Form

Patient Consent Form

 

XGP1000 

 

The XGP1000 is for patients who have failed their first line of treatment and are looking for other treatment options. It is a multi-gene test that analyses coding regions of over 1,000 known cancer genes in order to identify clinically actionable genetic alterations that may be missed by smaller gene panel tests. The genetic test will measure Tumour Mutation Burden (TMB).

Cancer Type

Solid Tumour

Sample Type

FFPE Tissue/ Whole Blood

TAT

28 days

Key documents

XGP1000 Gene List

Test Instructions

Request Form

Patient Consent Form